Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma - PubMed (original) (raw)
. 2009 Jan 6;15(1):67-78.
doi: 10.1016/j.ccr.2008.12.005.
Sebastian Horn, Markus Brockmann, Ursula Eilers, Lars Schüttrumpf, Nikita Popov, Anna Marie Kenney, Johannes H Schulte, Roderick Beijersbergen, Holger Christiansen, Bernd Berwanger, Martin Eilers
Affiliations
- PMID: 19111882
- DOI: 10.1016/j.ccr.2008.12.005
Free article
Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma
Tobias Otto et al. Cancer Cell. 2009.
Free article
Abstract
In human neuroblastoma, amplification of the MYCN gene predicts poor prognosis and resistance to therapy. In a shRNA screen of genes that are highly expressed in MYCN-amplified tumors, we have identified AURKA as a gene that is required for the growth of MYCN-amplified neuroblastoma cells but largely dispensable for cells lacking amplified MYCN. Aurora A has a critical function in regulating turnover of the N-Myc protein. Degradation of N-Myc requires sequential phosphorylation by cyclin B/Cdk1 and Gsk3. N-Myc is therefore degraded during mitosis in response to low levels of PI3-kinase activity. Aurora A interacts with both N-Myc and the SCF(Fbxw7) ubiquitin ligase that ubiquitinates N-Myc and counteracts degradation of N-Myc, thereby uncoupling N-Myc stability from growth factor-dependent signals.
Comment in
- Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastoma.
Maris JM. Maris JM. Cancer Cell. 2009 Jan 6;15(1):5-6. doi: 10.1016/j.ccr.2008.12.008. Cancer Cell. 2009. PMID: 19111875
Similar articles
- Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma.
Brockmann M, Poon E, Berry T, Carstensen A, Deubzer HE, Rycak L, Jamin Y, Thway K, Robinson SP, Roels F, Witt O, Fischer M, Chesler L, Eilers M. Brockmann M, et al. Cancer Cell. 2013 Jul 8;24(1):75-89. doi: 10.1016/j.ccr.2013.05.005. Epub 2013 Jun 20. Cancer Cell. 2013. PMID: 23792191 Free PMC article. - Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
Fujii Y, Yada M, Nishiyama M, Kamura T, Takahashi H, Tsunematsu R, Susaki E, Nakagawa T, Matsumoto A, Nakayama KI. Fujii Y, et al. Cancer Sci. 2006 Aug;97(8):729-36. doi: 10.1111/j.1349-7006.2006.00239.x. Cancer Sci. 2006. PMID: 16863506 Free PMC article. - Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
Xiao D, Yue M, Su H, Ren P, Jiang J, Li F, Hu Y, Du H, Liu H, Qing G. Xiao D, et al. Mol Cell. 2016 Nov 3;64(3):493-506. doi: 10.1016/j.molcel.2016.09.016. Epub 2016 Oct 20. Mol Cell. 2016. PMID: 27773673 - Regulation mechanism of Fbxw7-related signaling pathways (Review).
Zhou Z, He C, Wang J. Zhou Z, et al. Oncol Rep. 2015 Nov;34(5):2215-24. doi: 10.3892/or.2015.4227. Epub 2015 Aug 26. Oncol Rep. 2015. PMID: 26324296 Review. - N-myc and noncoding RNAs in neuroblastoma.
Buechner J, Einvik C. Buechner J, et al. Mol Cancer Res. 2012 Oct;10(10):1243-53. doi: 10.1158/1541-7786.MCR-12-0244. Epub 2012 Aug 30. Mol Cancer Res. 2012. PMID: 22936790 Review.
Cited by
- Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma.
Seneviratne JA, Ravindrarajah D, Carter DR, Zhai V, Lalwani A, Krishan S, Balachandran A, Ng E, Pandher R, Wong M, Nero TL, Wang S, Norris MD, Haber M, Liu T, Parker MW, Cheung BB, Marshall GM. Seneviratne JA, et al. Cancer Med. 2024 Nov;13(21):e70082. doi: 10.1002/cam4.70082. Cancer Med. 2024. PMID: 39501501 Free PMC article. - Tolerance of Oncogene-Induced Replication Stress: A Fuel for Genomic Instability.
Igarashi T, Yano K, Endo S, Shiotani B. Igarashi T, et al. Cancers (Basel). 2024 Oct 17;16(20):3507. doi: 10.3390/cancers16203507. Cancers (Basel). 2024. PMID: 39456601 Free PMC article. Review. - Unraveling molecular characteristics and tumor microenvironment dynamics of neuroendocrine prostate cancer.
Heimdörfer D, Artamonova N, Culig Z, Heidegger I. Heimdörfer D, et al. J Cancer Res Clin Oncol. 2024 Oct 16;150(10):462. doi: 10.1007/s00432-024-05983-0. J Cancer Res Clin Oncol. 2024. PMID: 39412660 Free PMC article. Review. - TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer.
Ye WL, Huang L, Yang XQ, Wan S, Gan WJ, Yang Y, He XS, Liu F, Guo X, Liu YX, Hu G, Li XM, Shi WY, He K, Wu YY, Wu WX, Lu JH, Song Y, Qu CJ, Wu H. Ye WL, et al. Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2406936121. doi: 10.1073/pnas.2406936121. Epub 2024 Oct 10. Proc Natl Acad Sci U S A. 2024. PMID: 39388269 - Exploring the dynamics and interactions of the N-myc transactivation domain through solution nuclear magnetic resonance spectroscopy.
Rejnowicz E, Batchelor M, Leen E, Ahangar MS, Burgess SG, Richards MW, Kalverda AP, Bayliss R. Rejnowicz E, et al. Biochem J. 2024 Nov 6;481(21):1535-1556. doi: 10.1042/BCJ20240248. Biochem J. 2024. PMID: 39370942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous